LiverUnit Profile Banner
Newcastle Liver Unit Profile
Newcastle Liver Unit

@LiverUnit

Followers
576
Following
90
Media
5
Statuses
161

Team of liver health professionals and scientists based in the Freeman Hospital and Institute of Transplantation, Newcastle. Retweets are not endorsements.

Freeman Hospital, Newcastle
Joined March 2020
Don't wanna be here? Send us removal request.
@stumcp
Stuart Mcpherson
2 years
Come and join us as #PhD student working on the SOLID study, evaluating liver fibrosis tests in Primary Care. https://t.co/4BgkzjdJxI @QAnstee
0
19
20
@LiverUnit
Newcastle Liver Unit
2 years
5 years of HCV testing & treatment in NE England Prisons. Great Collaborative working. -High rate of testing & treatment -HCV viraemia⬇️ -Progress towards Elimination @NuthHCVTeam @HepatitisCTrust Journal of Viral Hepatitis | Wiley Online Library https://t.co/ceA9S9SPWu
0
4
9
@LiverUnit
Newcastle Liver Unit
2 years
Great collaborative work between @NuthHCVTeam and @HepatitisCTrust showing the impact of a Hepatitis C 'test, trace and treat' programme using peer workers Journal of Viral Hepatitis | Wiley Online Library https://t.co/zuV3nJIWPs
0
5
9
@NatRevGastroHep
Nature Reviews Gastroenterology & Hepatology
2 years
New content online: Lifestyle interventions in nonalcoholic fatty liver disease https://t.co/tdJOkUpmkc
1
28
74
@LancetGastroHep
The Lancet Gastroenterology & Hepatology
2 years
New research - Huang et al - Type 2 diabetes, hepatic decompensation & hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis https://t.co/nEsc8Vs6AJ #LiverTwitter #Diabetes #NAFLD #MASLD
6
29
57
@basl_events
BASL
2 years
BASL2023 Annual Meeting - REGISTRATION OPEN -
0
3
3
@aelsharkawy75
Ahmed Elsharkawy
2 years
Honorary @EASLnews President Professor Maggie Bassendine (who I had the pleasure of working under @LiverUnit) gives an overview of the main changes since early days of Association. Highlights gender equality - some progress but still a way to go! #EASLCongress
0
5
22
@kmdrysdale
Kate Drysdale
2 years
Peer workers improve linkage to care for people who have hepatitis C in Newcastle @LiverUnit @HepatitisCTrust @stumcp
1
3
7
@LiverUnit
Newcastle Liver Unit
2 years
Come a join us at the Newcastle Liver Unit as a research fellow in fatty liver with @QAnstee. A fantastic project for a motivated individual. Further details can be found at: https://t.co/uCCCM0YBlJ
0
7
8
@haining_s
Shona Haining
2 years
Great work 👏@NIHRCRN_NENCumb collaboration between primary & secondary care to deliver more research @AejazAssistech
0
3
8
@JillDeane
Jill Deane
2 years
You can see we are DELIGHTED 😊 @NIHRCRN_NENCumb @stumcp @NHSRDForum 🙌🏽🙌🏽 #CHART
3
2
21
@stumcp
Stuart Mcpherson
3 years
What can you do when all treatment options have failed for chronic #hepatitisE and the patients has progressed to advanced fibrosis? Ledipasvir/sofosbuvir and ribavirin may be worth a try. https://t.co/ikTKmRIJmp #LiverTwitter @BASLedu @EASLedu
0
6
11
@stumcp
Stuart Mcpherson
3 years
Nice work from @SamJTingle looking at the impact of Donor Liver Blood tests on outcomes from liver transplantation. Peak ALT does not predict outcomes.
Tweet card summary image
journals.lww.com
This retrospective cohort study used the National Health Service registry on adult liver transplantation (2016–2019); adjusted regressions models were used to assess the effect of donor “liver blood...
2
5
9
@my_ueg
my_UEG
3 years
Nonalcoholic fatty liver disease is a highly prevalent & largely asymptomatic disease posing a major healthcare challenge. There's an urgent need for more sensitive, specific, independently validated & qualified biomarkers for use in #NAFLD. #UEGEdu ➡️ https://t.co/FYGPGSQ770
2
9
14
@Rob__Brierley
Rob Brierley
3 years
First results from the @LITMUS_IMI metacohort ❓Accuracy of 17 biomarkers in 966 adults w/ #NAFLD; 335 (35%) w/ at-risk #NASH ❌None met predefined acceptable AUC in detecting at-risk NASH (NAS≥4 & F≥2) ✅SomaSignal & ADAPT exceeded criteria for detecting F≥3 #livertwitter
@LancetGastroHep
The Lancet Gastroenterology & Hepatology
3 years
New research - Vali et al - Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study https://t.co/WGhWjp2heu #NASH #NAFLD #LiverTwitter @LITMUS_IMI
1
7
18
@UK_CLIF
UK_CLIF
2 years
Extremely productive #UKCLIF meeting! There are clearly challenges delivering research to improve care and outcomes for UK patients with decompensated cirrhosis, but there is enthusiasm to work collaboratively and innovate! Contact us to get involved! @RajivJalan1 @drgautammehta
0
15
22
@LiverTrust
British Liver Trust
2 years
We're proud to be working as part of the Obesity Health Alliance. 📺 80% of UK adults support the banning of advertising of unhealthy food on TV & online to kids. 🥤 68% would support an industry levy being extended beyond soft drinks. Read more:
britishlivertrust.org.uk
80% of UK adults support the Government banning advertising of unhealthy food on TV (79%) and online …
@OHA_updates
Obesity Health Alliance - Account Inactive
2 years
Our manifesto, launching today, represents the Alliance consensus on what the first steps should be to turn the tide on obesity. Delivering these policies will require political leadership. We are asking the leaders of all parties to #LeadOnChildHealth https://t.co/N1tVcjL772
0
2
5
@LiverUnit
Newcastle Liver Unit
2 years
Great work @NEndoscopy
@NEndoscopy
Prof John Leeds
2 years
Final our NIHR funded study is out!!! RFA primary ☑️ secondary ❎ Clinical and cost effectiveness of endoscopic bipolar radiofrequency ablation for the treatment of malignant biliary obstruction: a systematic review. Health Technol Assess. 2023 May;27(7):1-118.
0
0
1
@HansfordLouise
Louise Hansford 💙
2 years
In honour of #EuroTestWeek I am celebrating exceptional people committed to testing. Todays #HepC hero is the wonderful Kate @FreemanHospital whose diligence in tracking & tracing people is phenomenal. Kate will help ensure no one gets left behind in the #HepCULater mission.
3
3
16